nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.263	0.283	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.263	0.283	CbGbCtD
Midazolam—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.198	0.212	CbGbCtD
Midazolam—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.129	0.138	CbGbCtD
Midazolam—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.077	0.0828	CbGbCtD
Midazolam—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.0527	CcSEcCtD
Midazolam—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.0527	CcSEcCtD
Midazolam—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.0458	CcSEcCtD
Midazolam—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.0432	CcSEcCtD
Midazolam—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.039	CcSEcCtD
Midazolam—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.0341	CcSEcCtD
Midazolam—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.0306	CcSEcCtD
Midazolam—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.0295	CcSEcCtD
Midazolam—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0248	CcSEcCtD
Midazolam—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.0242	CcSEcCtD
Midazolam—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.0234	CcSEcCtD
Midazolam—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0229	CcSEcCtD
Midazolam—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.0228	CcSEcCtD
Midazolam—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.0227	CcSEcCtD
Midazolam—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0222	CcSEcCtD
Midazolam—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0219	CcSEcCtD
Midazolam—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.021	CcSEcCtD
Midazolam—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.0196	CcSEcCtD
Midazolam—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0189	CcSEcCtD
Midazolam—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0171	CcSEcCtD
Midazolam—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.0168	CcSEcCtD
Midazolam—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0151	CcSEcCtD
Midazolam—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0148	CcSEcCtD
Midazolam—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000969	0.0138	CcSEcCtD
Midazolam—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000964	0.0138	CcSEcCtD
Midazolam—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000942	0.0135	CcSEcCtD
Midazolam—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000918	0.0131	CcSEcCtD
Midazolam—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000909	0.013	CcSEcCtD
Midazolam—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000882	0.0126	CcSEcCtD
Midazolam—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000877	0.0125	CcSEcCtD
Midazolam—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00086	0.0123	CcSEcCtD
Midazolam—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000841	0.012	CcSEcCtD
Midazolam—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000816	0.0117	CcSEcCtD
Midazolam—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000794	0.0113	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000791	0.0113	CcSEcCtD
Midazolam—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000779	0.0111	CcSEcCtD
Midazolam—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00077	0.011	CcSEcCtD
Midazolam—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000764	0.0109	CcSEcCtD
Midazolam—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000749	0.0107	CcSEcCtD
Midazolam—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000742	0.0106	CcSEcCtD
Midazolam—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000686	0.0098	CcSEcCtD
Midazolam—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000681	0.00973	CcSEcCtD
Midazolam—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000679	0.00971	CcSEcCtD
Midazolam—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000672	0.00961	CcSEcCtD
Midazolam—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.00942	CcSEcCtD
Midazolam—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000658	0.00941	CcSEcCtD
Midazolam—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.00934	CcSEcCtD
Midazolam—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.00934	CcSEcCtD
Midazolam—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000629	0.009	CcSEcCtD
Midazolam—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000607	0.00867	CcSEcCtD
Midazolam—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000563	0.00804	CcSEcCtD
Midazolam—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000548	0.00783	CcSEcCtD
Midazolam—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00054	0.00772	CcSEcCtD
Midazolam—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000505	0.00722	CcSEcCtD
Midazolam—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000485	0.00694	CcSEcCtD
Midazolam—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000481	0.00688	CcSEcCtD
Midazolam—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000481	0.00688	CcSEcCtD
Midazolam—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000478	0.00684	CcSEcCtD
Midazolam—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000454	0.00648	CcSEcCtD
